OPX lands $17.5M for cheaper, faster biofuel production
OPX Biotechnologies, a biotech firm that focuses on engineering microorganisms to better break down organic products into cost-effective fuel sources, just closed its second round of funding at $17.5 million. The money will go toward construction of a demonstration plant slated to open in 2011 — laying the groundwork for broader commercialization a little over a year later.
This isn’t your standard ethanol or biodeisel production. OPX is altering the DNA of bacteria and fungi that… Continue Reading
Gevo raises another $17M for synthetic biofuels
Gevo, the Pasadena, Calif., based developer of synthetic biofuels just wrapped up a $17 million third round of funding. New investors Burrill & Co. and Malaysian Life Sciences Capital Fund joined cleantech regulars Khosla Ventures and Virgin Green Fund; the biofuel start-up has already raised over $30 million since the beginning of last year.
Like competitors LS9, OPX Biotechnologies and Amyris (see our prior coverage here, here and here), Gevo is trying to change the face… Continue Reading
OPX receives $3.6M for synthesized fuel replacement
updated
OPX Biotechnologies, a new startup that hopes to modify microorganisms to produce fuels similar to those we use for power generation today, has received $3.6 million in a first round of venture funding.
Although fuels like biodiesel and ethanol are also called biofuels, the term has a different meaning for companies like OPX. It, and a small handful of other companies, are modifying the DNA of bacteria, fungi and other lifeforms to cause them to produce… Continue Reading